| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 700655 | 09524001 | QUTENZA 179 mg PARCHE CUTANEO | QUTENZA 179 mg PARCHE CUTANEO 1 apósito | 179 mg | 74 | 1 | 69 | 1 apósito | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09524001/09524001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09524001/09524001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1236 | GRÜNENTHAL PHARMA S.A. | 2010-04-08 | 1 | 1 | 1 | 2010-04-08 | 2016-10-03 | 1 | 2011-10-18 | 665784 | View Edit Delete | |||||||||||
| 700642 | 03270001 | KENTERA 3,9 mg/24 HORAS, PARCHE TRANSDERMICO | KENTERA 3,9 mg/24 HORAS, PARCHE TRANSDERMICO, 8 parches | 3,9 mg/24 h | 74 | 8 | 28 | 8 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03270001/03270001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03270001/03270001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | LABORATORIOS GEBRO PHARMA S.A. | 2004-08-13 | 1 | 1 | 1 | 2004-08-13 | 2015-12-15 | 0 | 2014-05-29 | 827345 | View Edit Delete | |||||||||||
| 711553 | 02223001IP1 | EVRA 203 MICROGRAMOS/24 hORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 hORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 3 parches | 203 microgramos/24 h + 33,9 microgramos/24 h | 74 | 3 | 28 | 3 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223001IP1/02223001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223001IP1/02223001IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | ELAM PHARMA LABS S.L. | 2016-07-07 | 1 | 1 | 1 | 2016-07-08 | 2016-07-07 | 0 | 2016-12-02 | View Edit Delete | ||||||||||||
| 711554 | 02223002IP1 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 9 parches | 203 microgramos/24 h + 33,9 microgramos/24 h | 74 | 9 | 28 | 9 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223002IP1/02223002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223002IP1/02223002IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | ELAM PHARMA LABS S.L. | 2016-07-07 | 1 | 1 | 1 | 2016-07-08 | 2016-07-07 | 0 | 2016-12-13 | View Edit Delete | ||||||||||||
| 717546 | 64704 | ESTRADOT 50 microgramos/24 HORAS, PARCHE TRANSDERMICO | ESTRADOT 50 microgramos/24 HORAS, PARCHE TRANSDERMICO , 8 parches | 50 microgramos/24 h | 74 | 8 | 28 | 8 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64704/64704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64704/64704_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 2002-04-29 | 1 | 1 | 1 | 2002-04-29 | 2002-04-29 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 718346 | 64705 | ESTRADOT 75 microgramos/24 HORAS, PARCHE TRANSDERMICO | ESTRADOT 75 microgramos/24 HORAS, PARCHE TRANSDERMICO , 8 parches | 75 microgramos/24 h | 74 | 8 | 28 | 8 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64705/64705_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64705/64705_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 2002-04-29 | 1 | 1 | 1 | 2002-04-29 | 2002-04-29 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 719062 | 64707 | ESTRADOT 37,5 microgramos/24 HORAS, PARCHE TRANSDERMICO | ESTRADOT 37,5 microgramos/24 HORAS, PARCHE TRANSDERMICO , 8 parches | 37,5 microgramos/24 h | 74 | 8 | 28 | 8 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64707/64707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64707/64707_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23616 | BEXAL FARMACEUTICA S.A. | 2002-04-29 | 1 | 1 | 1 | 2002-04-29 | 2002-04-29 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 723772 | 02223001IP3 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 3 parches | 203 microgramos/24h + 33,9 microgramos/24h | 74 | 9 | 28 | 3 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223001IP3/02223001IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223001IP3/02223001IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | MELYFARMA S.L. | 2018-10-10 | 1 | 1 | 1 | 2018-10-11 | 2018-10-10 | 0 | 2019-10-14 | View Edit Delete | ||||||||||||
| 723797 | 02223002IP2 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS +33,9 MICROGRAMOS/24HORAS PARCHE TRANSDERMICO, 9 parches | 203 microgramos/24h + 33,9 microgramos/24h | 74 | 9 | 28 | 9 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223002IP2/02223002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223002IP2/02223002IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | MELYFARMA S.L. | 2018-10-10 | 1 | 1 | 1 | 2018-10-11 | 2018-10-10 | 0 | 2019-10-14 | View Edit Delete | ||||||||||||
| 725482 | 75829 | NICORETTE CLEAR 10 MG/16 HORAS PARCHES TRANSDERMICOS | NICORETTE CLEAR 10 MG/16 HORAS PARCHES TRANSDERMICOS 14 parches (Bolsa multilaminada en papel/lámina PET/copolímero de cicloole | 10 mg/16 h | 74 | 14 | 28 | 14 parches (Bolsa multilaminada en papel/lámina PET/copolímero de cicloole | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75829/75829_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75829/75829_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | JNTL CONSUMER HEALTH (SPAIN) S.L. | 2012-04-24 | 1 | 1 | 1 | 2012-04-24 | 2019-04-24 | 1 | 2021-05-13 | View Edit Delete | ||||||||||||
| 725484 | 75830 | NICORETTE CLEAR 15 MG/16 HORAS PARCHES TRANSDERMICOS | NICORETTE CLEAR 15 MG/16 HORAS PARCHES TRANSDERMICOS 14 parches (Bolsa multilaminada en papel/lámina PET/copolímero de cicloolefina extrusionado) | 15 mg/16 h | 74 | 14 | 28 | 14 parches (Bolsa multilaminada en papel/lámina PET/copolímero de cicloolef | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75830/75830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75830/75830_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68780 | JNTL CONSUMER HEALTH (SPAIN) S.L. | 2012-04-24 | 1 | 1 | 1 | 2012-04-24 | 2019-04-24 | 1 | 2020-05-12 | View Edit Delete | ||||||||||||
| 728195 | 98066025 | EXELON 9,5 mg/24 H PARCHE TRANSDERMICO | EXELON 9,5 mg/24 H PARCHE TRANSDERMICO, 60 (2 x 30) parches | 9,5 mg/24 h | 74 | 60 | 28 | 60 (2 x 30) parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066025/98066025_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066025/98066025_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-10-24 | 1 | 1 | 1 | 2007-10-24 | 2020-03-11 | 0 | 2020-12-10 | View Edit Delete | ||||||||||||
| 728206 | 98066020 | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 30 parches | 4,6 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066020/98066020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066020/98066020_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-10-24 | 1 | 1 | 1 | 2007-10-24 | 2020-03-11 | 0 | 2020-12-10 | View Edit Delete | ||||||||||||
| 728207 | 98066020 | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO | EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 60 (2 x 30) parches | 4,6 mg/24 h | 74 | 60 | 28 | 60 (2 x 30) parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98066020/98066020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98066020/98066020_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-10-24 | 1 | 1 | 1 | 2007-10-24 | 2020-03-11 | 0 | 2020-12-10 | View Edit Delete | ||||||||||||
| 728351 | 02223002IP3 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 9 parches | 203 microgramos/24 h + 33,9 microgramos/24 h | 74 | 9 | 28 | 9 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223002IP3/02223002IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223002IP3/02223002IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | ECOFAR PRODUCTOS S.L. | 2020-04-18 | 1 | 1 | 1 | 2020-04-19 | 2020-04-18 | 0 | 2020-04-20 | View Edit Delete | ||||||||||||
| 728353 | 02223001IP4 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 3 parches | 203 microgramos/24 h + 33,9 microgramos/24 h | 74 | 3 | 28 | 3 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223001IP4/02223001IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223001IP4/02223001IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6153 | ECOFAR PRODUCTOS S.L. | 2020-04-18 | 1 | 1 | 1 | 2020-04-19 | 2020-04-18 | 0 | 2020-04-20 | View Edit Delete | ||||||||||||
| 751008 | 60314 | CORDIPLAST 10 mg/24 h PARCHES TRANSDERMICOS | CORDIPLAST 10 mg/24 h PARCHES TRANSDERMICOS , 30 parches | 10 mg/24 h | 74 | 30 | 28 | 30 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60314/60314_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60314/60314_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 41928 | NORGINE DE ESPANA S.L.U. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 2003-02-14 | 0 | 2011-05-04 | 692459 | View Edit Delete | |||||||||||
| 734681 | 02223002 | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO | EVRA 203 MICROGRAMOS/24 HORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO, 9 parches | 203 microgramos/24 h + 33,9 microgramos/24 h | 74 | 9 | 28 | 9 parches | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02223002/02223002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02223002/02223002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | JANSSEN CILAG S.A. | 2003-02-04 | 1 | 1 | 1 | 2003-02-04 | 2003-02-04 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 758841 | 86148 | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS, 8 parches (papel / PET / PE / Al/ LasPolD | 4,6 mg/24 h | 74 | 8 | 28 | 8 parches (papel / PET / PE / Al/ LasPolD | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86148/86148_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86148/86148_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2021-08-10 | 1 | 1 | 1 | 2021-08-11 | 2022-10-25 | 0 | 2024-01-10 | View Edit Delete | ||||||||||||
| 758842 | 86148 | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS | ALZERTA DOS POR SEMANA 4,6 MG/24 H PARCHES TRANSDERMICOS, 16 parches (papel / PET / PE / Al/ LasPolD | 4,6 mg/24 h | 74 | 16 | 28 | 16 parches (papel / PET / PE / Al/ LasPolD | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86148/86148_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86148/86148_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2021-08-10 | 1 | 1 | 1 | 2021-08-11 | 2022-10-25 | 0 | 2024-02-20 | View Edit Delete |
Page 30 of 1036, showing 20 records out of 20715 total, starting on record 581, ending on 600